Literature DB >> 19519311

Safety of lumbar puncture procedures in patients with Alzheimer's disease.

E Peskind1, A Nordberg, T Darreh-Shori, H Soininen.   

Abstract

Changes in cerebrospinal fluid (CSF) biomarkers are representative of biochemical changes in the brain. Collection of CSF by lumbar puncture (LP) is essential for biomarker analysis, which is important for research in neurodegenerative disorders. However, LP for research purposes has been controversial due to a reported high incidence of severe LP headache when using standard 18g or 20g Quincke needles with a beveled cutting tip. A procedural safety analysis was performed using the database of a multicenter, 13-week study of CSF cholinesterase activity. A 24g Sprotte atraumatic needle was used to collect CSF at baseline and at Week 13 from 63 older patients with mild to moderate Alzheimer's disease. There was a < 2% LP headache incidence, and a favorable safety profile was reported. In conclusion, LP performed with a 24g Sprotte atraumatic needle (blunt, "bullet" tip) was a well tolerated procedure, with good acceptability.

Entities:  

Mesh:

Year:  2009        PMID: 19519311      PMCID: PMC4035477          DOI: 10.2174/156720509788486509

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  5 in total

1.  The importance of sex, age, needle size, height and body mass index in post-lumbar puncture headache.

Authors:  S T Vilming; R Kloster; L Sandvik
Journal:  Cephalalgia       Date:  2001-09       Impact factor: 6.292

2.  Safety and acceptability of the research lumbar puncture.

Authors:  Elaine R Peskind; Robert Riekse; Joseph F Quinn; Jeffrey Kaye; Christopher M Clark; Martin R Farlow; Charles Decarli; Charles Chabal; Darcy Vavrek; Murray A Raskind; Douglas Galasko
Journal:  Alzheimer Dis Assoc Disord       Date:  2005 Oct-Dec       Impact factor: 2.703

3.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

4.  Low frequency of post-lumbar puncture headache in demented patients.

Authors:  K Blennow; A Wallin; O Häger
Journal:  Acta Neurol Scand       Date:  1993-09       Impact factor: 3.209

5.  Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.

Authors:  T Darreh-Shori; O Almkvist; Z Z Guan; A Garlind; B Strandberg; A-L Svensson; H Soreq; E Hellström-Lindahl; A Nordberg
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

  5 in total
  25 in total

1.  Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array.

Authors:  Geoffrey S Baird; Sally K Nelson; Tracy R Keeney; Alex Stewart; Stephen Williams; Stephan Kraemer; Elaine R Peskind; Thomas J Montine
Journal:  Am J Pathol       Date:  2011-11-26       Impact factor: 4.307

Review 2.  Progress update: fluid and imaging biomarkers in Alzheimer's disease.

Authors:  Courtney L Sutphen; Anne M Fagan; David M Holtzman
Journal:  Biol Psychiatry       Date:  2013-09-05       Impact factor: 13.382

Review 3.  Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease.

Authors:  Kaj Blennow; Bruno Dubois; Anne M Fagan; Piotr Lewczuk; Mony J de Leon; Harald Hampel
Journal:  Alzheimers Dement       Date:  2014-05-03       Impact factor: 21.566

Review 4.  Cerebrospinal fluid biomarkers of Alzheimer's disease.

Authors:  Anne M Fagan; David M Holtzman
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

5.  NMR Metabolomics Analysis of Parkinson's Disease.

Authors:  Shulei Lei; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

6.  Reducing post-lumbar puncture headaches with small bore atraumatic needles.

Authors:  Eric D Vidoni; Jill K Morris; Kayla Raider; Jeffrey M Burns
Journal:  J Clin Neurosci       Date:  2013-10-22       Impact factor: 1.961

7.  Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease.

Authors:  Ozioma C Okonkwo; Michael L Alosco; H Randall Griffith; Michelle M Mielke; Leslie M Shaw; John Q Trojanowski; Geoffrey Tremont
Journal:  Arch Neurol       Date:  2010-06

8.  cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.

Authors:  Philipp Spitzer; Hans Wolfgang Klafki; Kaj Blennow; Luc Buée; Hermann Esselmann; Sanna-Kaisa Herruka; Connie Jimenez; Peter Klivenyi; Piotr Lewczuk; Juan Manuel Maler; Katrin Markus; Helmut E Meyer; Chris Morris; Thorsten Müller; Markus Otto; Lucilla Parnetti; Hilkka Soininen; Susanna Schraen; Charlotte Teunissen; Laszlo Vecsei; Henrik Zetterberg; Jens Wiltfang
Journal:  Int J Alzheimers Dis       Date:  2010-09-19

9.  Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI.

Authors:  Jon B Toledo; Sharon X Xie; John Q Trojanowski; Leslie M Shaw
Journal:  Acta Neuropathol       Date:  2013-06-29       Impact factor: 17.088

10.  Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.

Authors:  Agneta Nordberg; Taher Darreh-Shori; Elaine Peskind; Hilkka Soininen; Malahat Mousavi; Gina Eagle; Roger Lane
Journal:  Curr Alzheimer Res       Date:  2009-02       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.